Back to Awarded Treatment Trials


Awarded Trial: 03T-324

Grant ID

03T-324

Illness

Schizophrenia

Primary Drug/Intervention

Pravastatin

Primary Dosage

10mg/d

Secondary Drug Intervention

N/A

Secondary Dosage

N/A

Other Drug/Intervention

N/A

Other Dosage

N/A

Status

Completed

Investigator

Brar

Sample Size

60

Duration of Study Period for Each Subject

26 weeks

Outcome Measurements

PANSS, CDSS, RBANS, GAF

Results

Fifty-nine patients were randomized to receive adjunctive pravastatin or placebo. There were no significant differences between groups on measures of psychiatric symptoms or on cognitive tests.

Publication

N/A

Link

N/A

PI Name

Jaspreet Brar

Degree

MD

Center

CCS, Western Psychiatric Institute and Clinic

Institution

University of Pittsburgh

Address

3501 Forbes Avenue, Room 349

City or Town

Pittsburgh

State or Province

PA

Zip or Postal Code

15213

Country

USA

Email Address

brarjs@msx.upmc.edu